Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.25 is 54% below its 5-year average of 4.89, near the low end of its 5-year range (2.25–9.14).
As of the fiscal period ended Tuesday, June 30, 2026. 21.83% below its 12-month average of 2.88.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.25.
CURRENT RATIO
2.25
CURRENT RATIO AVG TTM
2.88
CURRENT RATIO AVG 3Y
3.40
CURRENT RATIO AVG 5Y
4.89
CURRENT RATIO AVG 10Y
5.34
CURRENT RATIO AVG 15Y
8.30
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-21.83%
CURRENT VS 3Y AVG
-33.60%
CURRENT VS 5Y AVG
-53.90%
CURRENT VS 10Y AVG
-57.81%
CURRENT VS 15Y AVG
-72.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-40.04%
vs the sector median at left
Market Cap
$681.27M
Current Ratio
13.82
TTM Avg
5.67
3Y Avg
7.51
5Y Avg
7.66
Market Cap
$685.49M
Current Ratio
14.20
TTM Avg
2.62
3Y Avg
2.46
5Y Avg
2.12
Market Cap
$691.79M
Current Ratio
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
Market Cap
$693.19M
Current Ratio
19.69
TTM Avg
6.38
3Y Avg
9.16
5Y Avg
11.87
Market Cap
$694.79M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | 2.25 | 2.88 | 3.40 | 4.89 |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | 13.82 | 5.67 | 7.51 | 7.66 |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | 14.20 | 2.62 | 2.46 | 2.12 |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 5.33 | 4.27 | 3.79 | 3.57 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | 8.86 | 10.22 | 11.35 | 25.38 |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | 19.69 | 6.38 | 9.16 | 11.87 |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | 9.99 | 4.68 | 3.00 | 2.74 |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | 4.48 | 5.45 | 6.78 | 8.00 |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 10.97 | 8.63 | 10.75 | 10.66 |
| Annexon, Inc. (ANNX)vs › | $660.29M | 5.53 | 8.02 | 10.47 | 14.43 |
Current Ratio
2.25
Quick Ratio
2.22
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.25 |
| 2026-03-31 | 3.04 |
| 2025-12-31 | 3.09 |
| 2025-09-30 | 2.58 |
| 2025-06-30 | 3.46 |
| 2025-03-31 | 3.50 |
| 2024-12-31 | 3.07 |
| 2024-09-30 | 3.23 |
| 2024-06-30 | 3.28 |
| 2024-03-31 | 4.40 |
| 2023-12-31 | 5.45 |
| 2023-09-30 | 7.33 |
| 2023-06-30 | 9.14 |
| 2023-03-31 | 5.32 |
| 2022-12-31 | 4.29 |
| 2022-09-30 | 4.97 |
| 2022-06-30 | 4.87 |
| 2022-03-31 | 6.72 |
| 2021-12-31 | 5.69 |
| 2021-09-30 | 8.03 |
| 2021-06-30 | 9.01 |
| 2021-03-31 | 10.78 |
| 2020-12-31 | 8.48 |
| 2020-09-30 | 5.00 |
| 2020-06-30 | 5.02 |
| 2020-03-31 | 5.78 |
| 2019-12-31 | 2.84 |
| 2019-09-30 | 5.47 |
| 2019-06-30 | 6.16 |
| 2019-03-31 | 7.57 |
| 2018-12-31 | 6.83 |
| 2018-09-30 | 2.97 |
| 2018-06-30 | 7.70 |
| 2018-03-31 | 4.45 |
| 2017-12-31 | 5.13 |
| 2017-09-30 | 3.12 |
| 2017-06-30 | 5.40 |
| 2017-03-31 | 5.59 |
| 2016-12-31 | 7.40 |
| 2016-09-30 | 14.04 |
| 2016-06-30 | 15.79 |
| 2016-03-31 | 16.42 |
| 2015-12-31 | 10.96 |
| 2015-09-30 | 11.15 |
| 2015-06-30 | 13.49 |
| 2015-03-31 | 14.26 |
| 2014-12-31 | 10.36 |
| 2014-09-30 | 11.27 |
| 2014-06-30 | 12.65 |
| 2014-03-31 | 16.67 |
| 2013-12-31 | 13.06 |
| 2013-09-30 | 17.70 |
| 2013-06-30 | 11.13 |
| 2013-03-31 | 20.13 |
| 2012-12-31 | 23.79 |
| 2012-09-30 | 15.01 |
| 2012-06-30 | 12.20 |
| 2012-03-31 | 14.15 |
| 2011-12-31 | 15.24 |
| 2011-09-30 | 30.79 |
| 2011-06-30 | 0.00 |
| 2011-03-31 | 0.00 |
